Yue et al. demonstrated that interleukin-10 (IL-10) knockout EPC-EVs significantly attenuated therapeutic efficacy in myocardial infarcted mice, by increasing infarcted area as well as reducing vascular regeneration after infarction, which was accomplished through enrichment of integrin-linked kinase (ILK) [117]. Here, ILK is linked to infarction.